Agouron Pharms Drug Patent Portfolio
Agouron Pharms owns 1 orange book drug protected by 6 US patents Given below is the list of Agouron Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5484926 | HIV protease inhibitors | 07 Apr, 2014 | Expired |
| US5952343 | HIV protease inhibitors | 07 Apr, 2014 | Expired |
| US6162812 | Pharmaceutical compositions containing HIV protease inhibitors and methods of their use | 07 Apr, 2014 | Expired |
| US5484926 | HIV protease inhibitors | 07 Oct, 2013 | Expired |
| US5952343 | HIV protease inhibitors | 07 Oct, 2013 | Expired |
| US6162812 | Pharmaceutical compositions containing HIV protease inhibitors and methods of their use | 07 Oct, 2013 | Expired |
Agouron Pharms's Family Patents
Agouron Pharms Drug List
Given below is the complete list of Agouron Pharms's drugs and the patents protecting them.
1. Viracept
Viracept is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5484926
(Pediatric)
| HIV protease inhibitors |
07 Apr, 2014
(10 years ago)
| Expired |
| US5952343
(Pediatric)
| HIV protease inhibitors |
07 Apr, 2014
(10 years ago)
| Expired |
| US6162812
(Pediatric)
| Pharmaceutical compositions containing HIV protease inhibitors and methods of their use |
07 Apr, 2014
(10 years ago)
| Expired |
| US5484926 | HIV protease inhibitors |
07 Oct, 2013
(11 years ago)
| Expired |
| US5952343 | HIV protease inhibitors |
07 Oct, 2013
(11 years ago)
| Expired |
| US6162812 | Pharmaceutical compositions containing HIV protease inhibitors and methods of their use |
07 Oct, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Viracept's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List